IBDEI0QC ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12950,1,2,0)
 ;;=2^SARCOMAS/OTH SOFT TISSUE CANCER
 ;;^UTILITY(U,$J,358.3,12950,2)
 ;;=^267165
 ;;^UTILITY(U,$J,358.3,12951,0)
 ;;=150.9^^78^810^16
 ;;^UTILITY(U,$J,358.3,12951,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12951,1,1,0)
 ;;=1^150.9
 ;;^UTILITY(U,$J,358.3,12951,1,2,0)
 ;;=2^ESOPHAGEAL CANCER
 ;;^UTILITY(U,$J,358.3,12951,2)
 ;;=^267055
 ;;^UTILITY(U,$J,358.3,12952,0)
 ;;=153.9^^78^810^15
 ;;^UTILITY(U,$J,358.3,12952,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12952,1,1,0)
 ;;=1^153.9
 ;;^UTILITY(U,$J,358.3,12952,1,2,0)
 ;;=2^COLON CANCER
 ;;^UTILITY(U,$J,358.3,12952,2)
 ;;=^267078
 ;;^UTILITY(U,$J,358.3,12953,0)
 ;;=152.9^^78^810^57
 ;;^UTILITY(U,$J,358.3,12953,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12953,1,1,0)
 ;;=1^152.9
 ;;^UTILITY(U,$J,358.3,12953,1,2,0)
 ;;=2^SMALL INTESTINE CANCER
 ;;^UTILITY(U,$J,358.3,12953,2)
 ;;=^267077
 ;;^UTILITY(U,$J,358.3,12954,0)
 ;;=193.^^78^810^62
 ;;^UTILITY(U,$J,358.3,12954,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12954,1,1,0)
 ;;=1^193.
 ;;^UTILITY(U,$J,358.3,12954,1,2,0)
 ;;=2^THYROID CANCER
 ;;^UTILITY(U,$J,358.3,12954,2)
 ;;=^267296
 ;;^UTILITY(U,$J,358.3,12955,0)
 ;;=284.9^^78^810^3
 ;;^UTILITY(U,$J,358.3,12955,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12955,1,1,0)
 ;;=1^284.9
 ;;^UTILITY(U,$J,358.3,12955,1,2,0)
 ;;=2^APLASTIC ANEMIA NOS
 ;;^UTILITY(U,$J,358.3,12955,2)
 ;;=^7020
 ;;^UTILITY(U,$J,358.3,12956,0)
 ;;=170.9^^78^810^6
 ;;^UTILITY(U,$J,358.3,12956,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12956,1,1,0)
 ;;=1^170.9
 ;;^UTILITY(U,$J,358.3,12956,1,2,0)
 ;;=2^BONE AND CARTILAGE CANCER
 ;;^UTILITY(U,$J,358.3,12956,2)
 ;;=^267155
 ;;^UTILITY(U,$J,358.3,12957,0)
 ;;=175.9^^78^810^9
 ;;^UTILITY(U,$J,358.3,12957,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12957,1,1,0)
 ;;=1^175.9
 ;;^UTILITY(U,$J,358.3,12957,1,2,0)
 ;;=2^BREAST CANCER-MALE
 ;;^UTILITY(U,$J,358.3,12957,2)
 ;;=^267205
 ;;^UTILITY(U,$J,358.3,12958,0)
 ;;=209.10^^78^810^10
 ;;^UTILITY(U,$J,358.3,12958,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12958,1,1,0)
 ;;=1^209.10
 ;;^UTILITY(U,$J,358.3,12958,1,2,0)
 ;;=2^CARCINOID, LARGE INTESTINE
 ;;^UTILITY(U,$J,358.3,12958,2)
 ;;=^336722
 ;;^UTILITY(U,$J,358.3,12959,0)
 ;;=209.29^^78^810^11
 ;;^UTILITY(U,$J,358.3,12959,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12959,1,1,0)
 ;;=1^209.29
 ;;^UTILITY(U,$J,358.3,12959,1,2,0)
 ;;=2^CARCINOID,NONBOWEL AND OTH SITE
 ;;^UTILITY(U,$J,358.3,12959,2)
 ;;=^336507
 ;;^UTILITY(U,$J,358.3,12960,0)
 ;;=209.00^^78^810^12
 ;;^UTILITY(U,$J,358.3,12960,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12960,1,1,0)
 ;;=1^209.00
 ;;^UTILITY(U,$J,358.3,12960,1,2,0)
 ;;=2^CARCINOID,SMALL INTESTINE
 ;;^UTILITY(U,$J,358.3,12960,2)
 ;;=^336721
 ;;^UTILITY(U,$J,358.3,12961,0)
 ;;=156.9^^78^810^13
 ;;^UTILITY(U,$J,358.3,12961,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12961,1,1,0)
 ;;=1^156.9
 ;;^UTILITY(U,$J,358.3,12961,1,2,0)
 ;;=2^CHOLANGIOCARCINOMA
 ;;^UTILITY(U,$J,358.3,12961,2)
 ;;=^267102
 ;;^UTILITY(U,$J,358.3,12962,0)
 ;;=286.9^^78^810^14
 ;;^UTILITY(U,$J,358.3,12962,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12962,1,1,0)
 ;;=1^286.9
 ;;^UTILITY(U,$J,358.3,12962,1,2,0)
 ;;=2^COAGULATION DEFECTS
 ;;^UTILITY(U,$J,358.3,12962,2)
 ;;=^87267
 ;;^UTILITY(U,$J,358.3,12963,0)
 ;;=156.9^^78^810^17
 ;;^UTILITY(U,$J,358.3,12963,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,12963,1,1,0)
 ;;=1^156.9
 ;;^UTILITY(U,$J,358.3,12963,1,2,0)
 ;;=2^GALLBLADDER CANCER
 ;;^UTILITY(U,$J,358.3,12963,2)
 ;;=^267102
 ;;^UTILITY(U,$J,358.3,12964,0)
 ;;=459.0^^78^810^19
 ;;^UTILITY(U,$J,358.3,12964,1,0)
 ;;=^358.31IA^2^2
